Illumina, Inc. (ETR:ILU)
98.86
+0.45 (0.46%)
Feb 20, 2025, 2:44 PM CET
Illumina Revenue
In the year 2024, Illumina had annual revenue of $4.37B USD, down -2.93%. Illumina had revenue of $1.10B in the quarter ending December 29, 2024, a decrease of -1.60%.
Revenue
$4.37B
Revenue Growth
-2.93%
P/S Ratio
n/a
Revenue / Employee
$484.16K
Employees
9,030
Market Cap
14.28B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 4.37B | -132.00M | -2.93% |
Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
Dec 29, 2019 | Pro | Pro | Pro |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 22.67B |
Merck KGaA | 20.96B |
Bayer Aktiengesellschaft | 46.74B |
Fresenius SE & Co. KGaA | 22.81B |
Sartorius Aktiengesellschaft | 3.38B |
Fresenius Medical Care AG | 19.24B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Illumina News
- 4 days ago - Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference - PRNewsWire
- 8 days ago - Calvin Klein blacklisting sends chill through US business in China - Financial Times
- 10 days ago - Trump's Cuts to Medical Research Are Hurting These Stocks - Barrons
- 12 days ago - Why Illumina (ILMN) Stock is Declining Today - GuruFocus
- 12 days ago - Why Illumina Stock Got Mashed on Monday - The Motley Fool
- 12 days ago - Illumina cut to underweight by Barclays, China woes cited - Seeking Alpha
- 12 days ago - This Illumina Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga
- 12 days ago - Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability - Seeking Alpha